Conceptualizing and prioritizing clinical trial outcomes from the perspectives of people with Parkinson's disease versus health care professionals: A concept mapping study

Quality of Life Research

Volumn 23, Issue 6, 2014, Pages 1687-1700

  Sjödahl Hammarlund, Catharina ^a,b   Nilsson, Maria H ^b   Idvall, Markus ^c   Rosas, Scott R ^d   Hagell, Peter ^a  

^a KRISTIANSTAD UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d Department of Research   (United States)

Author keywords

Concept mapping; Mixed method; Outcomes; Parkinson's disease; Qualitative; Quantitative

Indexed keywords

AGED; ARTICLE; CLUSTER ANALYSIS; COMPARATIVE STUDY; CONCEPT FORMATION; FEMALE; HEALTH CARE PERSONNEL; HEALTH SERVICE; HUMAN; INFORMATION PROCESSING; MALE; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; PARKINSON DISEASE; PSYCHOLOGICAL ASPECT; QUALITATIVE RESEARCH; QUALITY OF LIFE; SWEDEN; UTILIZATION REVIEW;

AGED; CLUSTER ANALYSIS; CONCEPT FORMATION; FEMALE; FOCUS GROUPS; HEALTH PERSONNEL; HEALTH SERVICES; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PARKINSON DISEASE; PATIENT OUTCOME ASSESSMENT; QUALITATIVE RESEARCH; QUALITY OF LIFE; RESEARCH DESIGN; SWEDEN;

EID: 84905276166     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-013-0614-3     Document Type: Article

References (38)

1. Jankovic, J. (2008). Parkinson's disease: Clinical features and diagnosis. Journal of Neurology, Neurosurgery and Psychiatry, 79(4), 368-376.
2. Chaudhuri, K. R., & Odin, P. (2010). The challenge of non-motor symptoms in Parkinson's disease. Progress in Brain Research, 184, 325-341.
3. Mayer, M. (2012). Seeking what matters: Patients as research partners. Patient, 5(2), 71-74.
4. Staniszewska, S., Haywood, K. L., Brett, J., & Tutton, L. (2012). Patient and public involvement in patient-reported outcome measures: Evolution not revolution. Patient, 5(2), 79-87. doi: 10.2165/11597150-000000000-00000.
5. World Health Organization, and World Bank. (2011). World report on disability. Geneva: World Health Organization.
6. Holmes, D. (2011). Patients have their say on research priorities. Lancet Neurology, 10(10), 874-875. doi: 10.1016/S1474-4422(11)70219-8.
7. Chalmers, I. (2007). The Alzheimer's Society, drug firms, and public trust. British Medical Journal, 335, 400.
8. EU Joint Programme - Neurodegenerative Disease Research. (2012). JPND research strategy - Tackling the challenge of Alzheimer's and other neurodegenerative diseases in Europe. UK Medical Research Council. Available from: http://www.neurodegenerationresearch.eu/fileadmin/Documents/2012/SRA- related/JPND-brochure-final-Hyperlink-2012.pdf. Accessed 30 Dec 2013.
9. Nisenzon, A. N., Robinson, M. E., Bowers, D., Banou, E., Malaty, I., & Okun, M. S. (2011). Measurement of patient-centered outcomes in Parkinson's disease: What do patients really want from their treatment? Parkinsonism & Related Disorders, 17(2), 89-94.
10. Sjodahl Hammarlund, C., Hagell, P., & Nilsson, M. H. (2012). Motor and non-motor predictors of illness-related distress in Parkinson's disease. Parkinsonism & Related Disorders, 18(3), 299-302. doi: 10.1016/j.parkreldis. 2011.10.015.
11. Sjodahl Hammarlund, C., Nilsson, M. H., & Hagell, P. (2012). Measuring outcomes in Parkinson's disease: A multi-perspective concept mapping study. Quality of Life Research, 21(3), 453-463. doi: 10.1007/s11136-011-9995-3.
12. Kane, M., & Trochim, W. M. K. (2007). Concept mapping for planning and evaluation. Thousand Oaks: Sage.
13. Trochim, W. M. K. (1989). An introduction to concept mapping for planning and evaluation. Evaluation and Program Planning, 12(1), 1-16.
14. Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression and mortality. Neurology, 17(5), 427-442.
15. Sturrock, K., & Rocha, J. (2000). A multidimensional scaling stress evaluation table. Field Methods, 12(1), 49-60.
16. Rosas, S. R., & Kane, M. (2012). Quality and rigor of the concept mapping methodology: A pooled study analysis. Evaluation and Program Planning, 35(2), 236-245.
17. Trochim, W. M. K. (1993). The reliability of concept mapping. In Paper presented at the annual conference of the American Evaluation Association, Dallas, TX, November 6, 1993.
18. Stillman, F. A., Schmitt, C. L., & Rosas, S. R. (2012). Opportunity for collaboration: A conceptual model of success in tobacco control and cancer prevention. Preventing Chronic Disease, 9, E02.
19. Jackson, D. A. (1995). PROTEST: A PROcrustean randomization TEST of community environment concordance. Ecoscience, 2(3), 297-303.
20. Peres-Neto, P. R., & Jackson, D. A. (2001). How well do multivariate data sets match? The advantages of a Procrustean superimposition approach over the Mantel test. Oecologia, 129, 169-178.
21. Schneider, J. W., & Borlund, P. (2007). Matrix comparison, part 2: Measuring the resemblance between proximity measures or ordination results by use of the Mantel and Procrustes statistics. Journal of the American Society for Information Science and Technology, 58(11), 1596-1609.
22. Eisenberg, L. (1977). Disease and illness. Distinctions between professional and popular ideas of sickness. Culture, Medicine and Psychiatry, 1(1), 9-23.
23. Helman, C. G. (1981). Disease versus illness in general practice. Journal of the Royal College of General Practitioners, 31(230), 548-552.
24. Hobart, J., & Cano, S. (2009). Improving the evaluation of therapeutic interventions in multiple sclerosis: The role of new psychometric methods. Health Technology Assessment, 13(12), iii, ix-x, 1-177.
25. Hobart, J., Cano, S., Baron, R., Thompson, A., Schwid, S., Zajicek, J., et al. (2013). Achieving valid patient-reported outcomes measurement: A lesson from fatigue in multiple sclerosis. Multiple Sclerosis, 19(13), 1773-1783. doi: 10.1177/1352458513483378.
26. Antonini, A., Martinez-Martin, P., Chaudhuri, R. K., Merello, M., Hauser, R., Katzenschlager, R., et al. (2011). Wearing-off scales in Parkinson's disease: Critique and recommendations. Movement Disorders, 26(12), 2169-2175.
27. Den Oudsten, B. L., Van Heck, G. L., & De Vries, J. (2007). The suitability of patient-based measures in the field of Parkinson's disease: A systematic review. Movement Disorders, 22(10), 1390-1401.
28. Hogl, B., Arnulf, I., Comella, C., Ferreira, J., Iranzo, A., Tilley, B., et al. (2010). Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations. Movement Disorders, 25(16), 2704-2716.
29. Schrag, A., Barone, P., Brown, R. G., Leentjens, A. F., McDonald, W. M., Starkstein, S., et al. (2007). Depression rating scales in Parkinson's disease: Critique and recommendations. Movement Disorders, 22(8), 1077-1092.
30. Tomlinson, C. L., Patel, S., Meek, C., Herd, C. P., Clarke, C. E., Stowe, R., et al. (2012). Physiotherapy intervention in Parkinson's disease: Systematic review and meta-analysis. British Medical Journal, 345, e5004.
31. Tyson, S., & Connell, L. (2009). The psychometric properties and clinical utility of measures of walking and mobility in neurological conditions: A systematic review. Clinical Rehabilitation, 23(11), 1018-1033.
32. Brown, C. A., Cheng, E. M., Hays, R. D., Vassar, S. D., & Vickrey, B. G. (2009). SF-36 includes less Parkinson's disease (PD)-targeted content but is more responsive to change than two PD-targeted health-related quality of life measures. Quality of Life Research, 18(9), 1219-1237.
33. Hagell, P., & Nilsson, M. H. (2009). The 39-item Parkinson's disease questionnaire (PDQ-39): Is it a unidimensional Construct? Therapeutic Advances in Neurological Disorders, 2(4), 205-214. doi: 10.1177/1756285609103726.
34. Hagell, P., & Nygren, C. (2007). The 39 item Parkinson's disease questionnaire (PDQ-39) revisited: Implications for evidence based medicine. Journal of Neurology, Neurosurgery and Psychiatry, 78(11), 1191-1198.
35. Hagell, P., Reimer, J., & Nyberg, P. (2009). Whose quality of life? Ethical implications in patient-reported health outcome measurement. Value in Health, 12(4), 613-617. doi: 10.1111/j.1524-4733.2008.00488.x.
36. Lee, M. A., Walker, R. W., Hildreth, A. J., & Prentice, W. M. (2006). Individualized assessment of quality of life in idiopathic Parkinson's disease. Movement Disorders, 21(11), 1929-1934.
37. Hobart, J. C., Cano, S. J., Zajicek, J. P., & Thompson, A. J. (2007). Rating scales as outcome measures for clinical trials in neurology: Problems, solutions, and recommendations. Lancet Neurology, 6(12), 1094-1105.
38. Wilson, M. (2005). Constructing measures: An item response modelling approach. Mahwah, NJ: Lawrence Erlbaum.